Patent · US Active

Method of assessing pancreatic beta-cell function

US10302663B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignee

METABOLON, INC. · US

Inventors

Walter Gall · Chapel Hill, US
Kay A. Lawton · Raleigh, US

Key dates

Filing date	Sep 11, 2012
Grant date	May 28, 2019
Priority date	—
Expiry date	May 3, 2036

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T436/201666
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Biomarkers relating to pancreatic Beta-cell function, pancreatic Beta-cell glucose sensitivity, insulin resistance, and/or pancreatic Beta-cell-related disorders are provided. Methods based on the same biomarkers are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.